This Article Full Text (PDF) All Versions of this Article: theoncologist.2008-0270v1 14/2/110    most recent eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doroshow, J. H. Articles by Niederhuber, J. E. Search for Related Content PubMed PubMed Citation Articles by Doroshow, J. H. Articles by Niederhuber, J. E.

Five Strategies for Accelerating the War on Cancer in an Era of Budget Deficits

^aNational Cancer Institute, Bethesda, Maryland, USA

Correspondence: Correspondence: James H. Doroshow, M.D., National Cancer Institute, 31 Center Drive, Room 3A44, Bethesda, Maryland 20892, USA. Telephone: 301-496-4291; Fax: 301-496-0826; e-mail: doroshoj{at}mail.nih.gov

Received December 12, 2008; accepted for publication January 5, 2009.

Disclosure: The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the authors, planners, independent peer reviewers, or staff managers.

In recent years, the National Institutes of Health's largest institute, the National Cancer Institute (NCI), has adapted to difficult economic conditions by leveraging its robust infrastructure—which includes risk factor surveillance and population monitoring, research centers (focused on basic, translation, clinical, and behavioral sciences), clinical trials and health care research networks, and rigorously validated statistical models—to maximize the impact of scientific progress on the public health. To continue advancement and realize the opportunity of significant, population-level changes in cancer mortality, the NCI recommends that five national-level actions be taken: (1) significantly increase enrollment of Medicare patients into cancer clinical trials through adequate physician reimbursement, (2) increase NCI/Centers for Medicare and Medicaid Services collaboration on clinical trials research to evaluate the therapeutic efficacy of anticancer drugs, (3) establish a national outcomes research demonstration project to test strategies for measuring and improving health care quality and provide an evidence base for public policy, (4) leverage existing tobacco-control collaborations and possible new authorities at the U.S. Food and Drug Administration to realize the outstanding health gains possible from a reduction in tobacco use, and (5) increase colorectal cancer screening rates though intensified collaboration between federal agencies working to address barriers to access and use of screening. These cost-effective strategies provide the opportunity for extraordinary results in an era of budget deficits. Of the chronic diseases, cancer has the strongest national research infrastructure that can be leveraged to produce rapid results to inform budget prioritization and public policy, as well as mobilize new projects to answer critical public health questions.

This article has been cited by other articles:

				B. A. Chabner The National Cancer Institute and Its Director: Worthy of Our Full Support Oncologist, February 1, 2009; 14(2): 108 - 109. [Full Text] [PDF]